Human Microbiome Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Disease (Diabetes, Central Nervous System Disorders, Cancer, Obesity, Others), By Application (Therapeutic, Diagnostic), By Product (Medical Food, Probiotics, Prebiotics, Supplements, Others), And By Geography - Forecasts From 2023 to 2028

The human microbiome market will grow at a CAGR of 20.42% to reach US$2,383.317 million in 2030 from US$941.215 million in 2025.

Major factors driving the global human microbiome market growth are increasing instances of lifestyle diseases, diarrheal infections, predominant changes in the lifestyle of the global population, and an increase in the aged population and its applications in healthcare. Moreover, technological enhancements in biomedical sciences and growing research investment in technology and product sectors is also positively impacting the market growth positively. However, lack of awareness about the use and advantages of prebiotics and probiotics and government restrictions on their usage are major challenges for the market players.

The global human microbiome market report provides a detailed analysis of the industry landscape, offering strategic and executive-level insights supported by data-driven forecasts and analysis. This regularly updated report equips decision-makers with actionable intelligence on current market trends, emerging opportunities, and competitive dynamics. It explores consumer demand across various regions and product types, such as therapeutics, diagnostics, and probiotics, while also examining purchasing behaviours and key customer segments. Additionally, the report delves into technological advancements, key government policies, regulation.

Global Human Microbiome Market Segmentations:

Global Human Microbiome Market Segmentation by product:

The market analyzed by product into the following:

• Probiotic
• Prebiotics
• Supplements
• Others

Global Human Microbiome Market Segmentation by disease:

The market analyzed by disease into the following:

• Diabetes
• Autoimmune Disorder
• Cancer
• Obesity
• Others

Global Human Microbiome Market Segmentation by application:

The market analyzed by application into the following:

• Diagnostics
• Therapeutics

Global Human Microbiome Market Segmentation by regions:

The study also analysed the global human microbiome market into the following regions, with country level forecasts and analysis as below:

• North America (US, Canada and Mexico)
• South America (Brazil, Argentina, and Others)
• Europe (Germany, France, United Kingdom, Spain, Italy and Others
• Middle East and Africa (Saudi Arabia, UAE and Others)
• Asia Pacific (China, India, Japan, South Korea, Thailand and Others)

Global Human Microbiome Market Competitive Landscape:

The global human microbiome market features key players such as Seres Therapeutics, Microbiome Therapeutics Innovation Group, Vedanta Biosciences Inc., Metabiomics, Ferring Pharmaceuticals, Finch Therapeutics, BiomeBank, Biohm Technologies, Resbiotic, Immuron Limited, Maat Pharma among others.

Global Human Microbiome Market Report Coverage:

This report provides extensive coverage as explained in the points below:

• Market size, forecasts, and trends by product, with historical revenue data and analysis focusing on key factors driving adoption, current challenges faced by key players, and major growth areas.
• Market size, forecasts, and trends by disease, with historical revenue data and analysis.
• Market size, forecasts, and trends by application, with historical revenue data and analysis.
• The global human microbiome market is also analysed across different regions, with historical data, regional share, attractiveness and opportunity of these solutions in different countries. The growth prospects and key players operating in these markets. The section also dwells on the macro factors, economic scenario and other complementing factors aiding in market growth. 
• Market dynamics: The section details the market growth factors, restraints, and opportunities in the market. The segment also presents complete market scenario with the help of Porter’s five forces model. 
• Competitive Intelligence: A thorough investigation on the competitive structure of the market presented through proprietary vendor matrix model, market share analysis of key players, insights on strategies of key players and recent major developments undertaken by the companies to gain competitive edge. 
• Research methodology: The assumptions and sources which were considered to arrive at the final market estimates. Additionally, how our model is refined to ensure most significant factors are taken into consideration with the proper hypothesis and bottom-up and top-down approaches enhance the reliability of forecasts further strengthening the trustworthiness of the numbers being presented. 

How this report is helpful to you and reasons for purchase?

• The report provides a strategic outlook of the human microbiome market to the decision-makers, analysts and other stakeholders in the easy to read format for taking informed decisions.
• The charts, tables and figures make it easy for the executives to gain valuable insights while skimming the report. 
• Analyst support through calls and email for timely clarification and incorporating additional requests. 
• Option of presentation or doc format with the estimates file to take care of diverse requirements. 
• 15% FREE customization with all our reports help cater additional requirements with significant cost-savings. 
• Option of purchasing specific segments of the study, including opting for summary reports or just the estimates file. 

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL HUMAN MICROBIOME MARKET BY PRODUCT

5.1. Introduction

5.2. Probiotics

5.3. Prebiotics

5.4. Supplements

5.5. Others

6. GLOBAL HUMAN MICROBIOME MARKET BY DISEASE

6.1. Introduction

6.2. Diabetes

6.3. Autoimmune Disorder

6.4. Cancer

6.5. Obesity

6.6. Others

7. GLOBAL HUMAN MICROBIOME MARKET BY APPLICATON

7.1. Introduction

7.2. Diagnostics

7.3. Therapeutics

8. GLOBAL HUMAN MICROBIOME MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. USA

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. Germany

8.4.2. France

8.4.3. United Kingdom

8.4.4. Spain

8.4.5. Italy

8.4.6. Others

8.5. Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Others

8.6. Asia Pacific

8.6.1. China

8.6.2. India

8.6.3. Japan

8.6.4. South Korea

8.6.5. Thailand

8.6.6. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. Seres Therapeutics

10.2. Microbiome Therapeutics Innovation Group

10.3. Vedanta Biosciences Inc.

10.4. Metabiomics

10.5. Ferring Pharmaceuticals

10.6. Finch Therapeutics

10.7. BiomeBank

10.8. Biohm Technologies

10.9. Resbiotic

10.10. Immuron Limited

10.11. Maat Pharma

11. APPENDIX

11.1. Currency 

11.2. Assumptions

11.3. Base and Forecast Years Timeline

11.4. Key benefits for the stakeholders

11.5. Research Methodology 

11.6. Abbreviations 

LIST OF FIGURES

LIST OF TABLES

Seres Therapeutics

Microbiome Therapeutics Innovation Group

Vedanta Biosciences Inc.

Metabiomics

Ferring Pharmaceuticals

Finch Therapeutics

BiomeBank

Biohm Technologies

Resbiotic

Immuron Limited

Maat Pharma